Stock Scorecard



Stock Summary for Utah Medical Products Inc (UTMD)

Total Score

21 out of 29

Currently on the following lists
Dividend Stock List
Tim's Recommendation
Buy

Growth List Algorithm Criteria for UTMD

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for UTMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for UTMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for UTMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for UTMD

Company Overview

Company Name Utah Medical Products Inc
Country USA
Description Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2022
Next Earnings Date 1/30/2023

Stock Price History

Last Day Price 91.71
Last Day Volume 2,322
Average Daily Volume 5,714
52-Week High 120.94
52-Week Low 79.83
Last Price to 52 Week Low 14.88 %

Valuation Measures

Trailing PE 20.89
Industry PE 128.77
Sector PE 93.04
5-Year Average PE 22.30
Free Cash Flow Ratio 4.79
Industry Free Cash Flow Ratio 33.37
Sector Free Cash Flow Ratio 37.55
Book Value Per Share Most Recent Quarter 29.84
Price to Book Ratio 3.07
Industry Price to Book Ratio 5.48
Sector Price to Book Ratio 15.35
Price to Sales Ratio Twelve Trailing Months 6.44
Industry Price to Sales Ratio Twelve Trailing Months 8.56
Sector Price to Sales Ratio Twelve Trailing Months 25.22

Share Statistics

Total Shares Outstanding 3,627,600
Market Capitalization 332,687,196
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 12/15/2022
Last Dividend Amount 0.29
Current Dividend Amount 0.30
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 2.87
Trailing Annual Dividend Yield 1.27 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 21
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 2.40 %
Annual Earnings Growth 36.95 %
Reported EPS Past Year 3.26
Reported EPS Prior Year 4.05
Net Income Twelve Trailing Months 16,048,000
Net Income Past Year 14,788,000
Net Income Prior Year 10,798,000
Quarterly Revenue Growth YOY 3.00 %
5-Year Revenue Growth 4.41 %

Balance Sheet

Total Cash Per Share 19.16
Total Cash Most Recent Quarter 69,511,000
Total Cash Past Year 60,974,000
Total Cash Prior Year 51,590,000
Net Cash Position Most Recent Quarter 69,511,000
Net Cash Position Past Year 60,974,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Current Ratio Most Recent Quarter 13.44
Total Stockholder Equity Past Year 107,138,000
Total Stockholder Equity Prior Year 102,822,000
Total Stockholder Equity Most Recent Quarter 108,186,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

MACD 0.93
MACD Signal 0.72
20-Day Bollinger Lower Band 81.37
20-Day Bollinger Middle Band 88.55
20-Day Bollinger Upper Band 95.73
Beta 0.30
RSI 55.69
50-Day SMA 88.97
200-Day SMA 86.93

System

Modified 11/25/2022 7:23:34 AM